Siemens Healthcare Diagnostics Inc. is recalling 21,112 RAPIDPoint 500 and RAPIDPoint 500e Blood Gas Systems due to a technical defect where certain medications can interfere with blood tests. The drugs Perhexiline Maleate and Atomoxetine Hydrochloride can cause the systems to report falsely elevated sodium levels. This recall affects all units and software versions of these diagnostic systems, which were distributed nationwide in the United States and to over 100 foreign countries. Because these incorrect results can lead to unrecognized low sodium (hyponatremia) or inappropriate treatment for high sodium, patients may experience delays in diagnosis or improper medical management.
The interference from specific medications causes a positive bias in sodium readings, meaning the reported level is higher than the patient's actual sodium level. This can mask a dangerously low sodium condition or cause doctors to treat a high sodium condition that does not exist, potentially leading to iatrogenic hyponatremia and serious patient harm.
Manufacturer notification and guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.